Moleculin Biotech, Inc. (MBRX) Form 424B5 — Aug 3, 2026
Moleculin Biotech has filed a prospectus supplement for a best efforts public offering of up to 11.1 million shares of common stock and accompanying common warrants at a combined public offering price of $0.75 per share and warrant. The offering price represents a substantial discount of approximately 66% to the last reported sale price of $2.19 per share. The transaction will result in immediate dilution, increasing the number of outstanding shares from approximately 7.1 million to 18.2 million, excluding the potential exercise of warrants.
Key figures
- Offering Price
- 0.75
- Shares Offered
- 11088334
- Last sale price
- 2.19
- Warrants offered
- 37130001
- Warrants per share
- 3
- Net proceeds estimate
- 8500000
- Warrant exercise price
- 0.75
- Pre funded warrants offered
- 1288333
- Insider participation shares
- 1319998
Price after filing
Close on the filing date to close N calendar days later (from $0.42). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.